This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-20a-5p | ABCA1 | 0.02 | 0.94502 | 0.12 | 0.63155 | MirTarget; miRNATAP | -0.24 | 0 | NA | |
2 | hsa-miR-20a-5p | ABCA3 | 0.02 | 0.94502 | -0.09 | 0.71876 | miRNAWalker2 validate | -0.16 | 0 | NA | |
3 | hsa-miR-20a-5p | ABCD2 | 0.02 | 0.94502 | -0.45 | 0.01817 | MirTarget | -0.2 | 0.00297 | NA | |
4 | hsa-miR-20a-5p | ABHD2 | 0.02 | 0.94502 | 0.31 | 0.32233 | miRNATAP | -0.3 | 0 | NA | |
5 | hsa-miR-20a-5p | ABHD5 | 0.02 | 0.94502 | 0.36 | 0.11787 | MirTarget | -0.1 | 0 | NA | |
6 | hsa-miR-20a-5p | ACER3 | 0.02 | 0.94502 | 0.44 | 0.02509 | mirMAP | -0.13 | 1.0E-5 | NA | |
7 | hsa-miR-30d-5p | ACTC1 | 0.11 | 0.82546 | -0.22 | 0.31363 | MirTarget; miRNATAP | -0.27 | 0.00806 | NA | |
8 | hsa-miR-30d-5p | ACTN1 | 0.11 | 0.82546 | 0.09 | 0.78189 | miRNATAP | -0.11 | 0.00058 | NA | |
9 | hsa-miR-30d-5p | ACVR1 | 0.11 | 0.82546 | 0.1 | 0.65249 | MirTarget; miRNATAP | -0.21 | 0 | NA | |
10 | hsa-miR-20a-5p | ACVR1B | 0.02 | 0.94502 | -0.17 | 0.45572 | miRNATAP | -0.13 | 0 | NA | |
11 | hsa-miR-30d-5p | ADAM19 | 0.11 | 0.82546 | 0.58 | 0.00069 | MirTarget; miRNATAP | -0.42 | 0 | NA | |
12 | hsa-miR-20a-5p | ADAM22 | 0.02 | 0.94502 | -0.35 | 0.03223 | MirTarget; mirMAP | -0.41 | 0 | NA | |
13 | hsa-miR-30d-5p | ADAMTS3 | 0.11 | 0.82546 | -0.07 | 0.61975 | miRNATAP | -0.18 | 0.0074 | NA | |
14 | hsa-miR-20a-5p | ADAMTS5 | 0.02 | 0.94502 | -0.11 | 0.64807 | miRNATAP | -0.25 | 0 | NA | |
15 | hsa-miR-30d-5p | ADAMTS6 | 0.11 | 0.82546 | -0.14 | 0.20848 | MirTarget; miRNATAP | -0.45 | 0 | NA | |
16 | hsa-miR-30d-5p | ADAMTS9 | 0.11 | 0.82546 | -0.15 | 0.47467 | miRNATAP | -0.13 | 0.01679 | NA | |
17 | hsa-miR-30d-5p | ADAP2 | 0.11 | 0.82546 | 0.01 | 0.95469 | miRNAWalker2 validate | -0.19 | 0 | NA | |
18 | hsa-miR-20a-5p | ADCY1 | 0.02 | 0.94502 | -0.53 | 0.0372 | mirMAP | -0.49 | 0 | NA | |
19 | hsa-miR-20a-5p | ADCY9 | 0.02 | 0.94502 | -0.32 | 0.16325 | mirMAP | -0.3 | 0 | NA | |
20 | hsa-miR-20a-5p | ADRA2A | 0.02 | 0.94502 | -0.93 | 8.0E-5 | miRNATAP | -0.51 | 0 | NA | |
21 | hsa-miR-30d-5p | ADRA2A | 0.11 | 0.82546 | -0.93 | 8.0E-5 | MirTarget; miRNATAP | -0.24 | 0.00134 | NA | |
22 | hsa-miR-30d-5p | AFF2 | 0.11 | 0.82546 | -0.15 | 0.30344 | mirMAP | -0.22 | 0.00382 | NA | |
23 | hsa-miR-20a-5p | AFF4 | 0.02 | 0.94502 | 0.1 | 0.74149 | miRNATAP | -0.28 | 0 | NA | |
24 | hsa-miR-20a-5p | AGA | 0.02 | 0.94502 | 0.14 | 0.47698 | MirTarget | -0.12 | 0 | NA | |
25 | hsa-miR-20a-5p | AGFG2 | 0.02 | 0.94502 | -0.41 | 0.02454 | miRNATAP | -0.11 | 0 | NA | |
26 | hsa-miR-20a-5p | AGPS | 0.02 | 0.94502 | 0.49 | 0.04908 | mirMAP | -0.19 | 0 | NA | |
27 | hsa-miR-20a-5p | AHNAK | 0.02 | 0.94502 | -0.28 | 0.54705 | miRNATAP | -0.4 | 0 | NA | |
28 | hsa-miR-30d-5p | AIDA | 0.11 | 0.82546 | 0.13 | 0.59154 | MirTarget | -0.11 | 0 | NA | |
29 | hsa-miR-20a-5p | AKAP13 | 0.02 | 0.94502 | 0.02 | 0.95598 | MirTarget; mirMAP; miRNATAP | -0.14 | 0 | NA | |
30 | hsa-miR-20a-5p | AKT3 | 0.02 | 0.94502 | -0.08 | 0.72155 | miRNATAP | -0.14 | 0.00014 | NA | |
31 | hsa-miR-20a-5p | ALDH1A3 | 0.02 | 0.94502 | 0.17 | 0.51186 | mirMAP | -0.12 | 0.01839 | NA | |
32 | hsa-miR-20a-5p | ALDH3A2 | 0.02 | 0.94502 | -0.13 | 0.63153 | mirMAP | -0.17 | 0 | NA | |
33 | hsa-miR-20a-5p | ALPK3 | 0.02 | 0.94502 | -0.06 | 0.72466 | mirMAP | -0.23 | 0 | NA | |
34 | hsa-miR-30d-5p | ALPK3 | 0.11 | 0.82546 | -0.06 | 0.72466 | miRNATAP | -0.18 | 0.00039 | NA | |
35 | hsa-miR-20a-5p | ALX4 | 0.02 | 0.94502 | -1.27 | 0 | miRNATAP | -0.17 | 0.01923 | NA | |
36 | hsa-miR-30d-5p | AMMECR1 | 0.11 | 0.82546 | 0.53 | 0.00187 | miRNATAP | -0.12 | 0.00249 | NA | |
37 | hsa-miR-30d-5p | AMOTL1 | 0.11 | 0.82546 | -0.17 | 0.5134 | MirTarget; miRNATAP | -0.13 | 0.02152 | NA | |
38 | hsa-miR-20a-5p | ANK2 | 0.02 | 0.94502 | -0.71 | 0.00097 | MirTarget; miRNATAP | -0.27 | 0 | NA | |
39 | hsa-miR-20a-5p | ANKRD12 | 0.02 | 0.94502 | 0.1 | 0.68323 | MirTarget | -0.21 | 0 | NA | |
40 | hsa-miR-20a-5p | ANKRD29 | 0.02 | 0.94502 | -1.02 | 0 | MirTarget | -0.3 | 0 | NA | |
41 | hsa-miR-20a-5p | ANKRD50 | 0.02 | 0.94502 | 0.13 | 0.60536 | MirTarget; miRNATAP | -0.27 | 0 | NA | |
42 | hsa-miR-20a-5p | ANO6 | 0.02 | 0.94502 | 0.09 | 0.76604 | MirTarget | -0.26 | 0 | NA | |
43 | hsa-miR-30d-5p | ANTXR1 | 0.11 | 0.82546 | 0.34 | 0.2722 | mirMAP | -0.4 | 0 | NA | |
44 | hsa-miR-30d-5p | ANTXR2 | 0.11 | 0.82546 | -0.11 | 0.66549 | mirMAP | -0.26 | 0 | NA | |
45 | hsa-miR-30d-5p | ANXA11 | 0.11 | 0.82546 | -0.15 | 0.61377 | mirMAP | -0.13 | 0 | NA | |
46 | hsa-miR-20a-5p | AP3S2 | 0.02 | 0.94502 | 0.13 | 0.61416 | miRNAWalker2 validate; mirMAP | -0.14 | 0 | NA | |
47 | hsa-miR-20a-5p | APBB2 | 0.02 | 0.94502 | -0.13 | 0.64936 | MirTarget; miRNATAP | -0.39 | 0 | NA | |
48 | hsa-miR-20a-5p | AR | 0.02 | 0.94502 | -0.71 | 0.01216 | mirMAP | -1.27 | 0 | NA | |
49 | hsa-miR-30d-5p | AR | 0.11 | 0.82546 | -0.71 | 0.01216 | mirMAP | -0.52 | 2.0E-5 | 27683042 | Inhibition of endogenous miR-30b-3p and miR-30d-5p enhanced AR expression and androgen-independent cell growth; MiR-30d-5p levels were inversely correlated with AR activity as measured by PSA mRNA in metastatic CRPC |
50 | hsa-miR-30d-5p | ARCN1 | 0.11 | 0.82546 | 0.42 | 0.18003 | mirMAP | -0.1 | 2.0E-5 | NA | |
51 | hsa-miR-30d-5p | ARF4 | 0.11 | 0.82546 | 0.3 | 0.33656 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
52 | hsa-miR-20a-5p | ARFGEF2 | 0.02 | 0.94502 | 0.37 | 0.18628 | miRNAWalker2 validate | -0.17 | 0 | NA | |
53 | hsa-miR-20a-5p | ARHGAP1 | 0.02 | 0.94502 | -0.1 | 0.72274 | MirTarget; miRNATAP | -0.1 | 0 | NA | |
54 | hsa-miR-20a-5p | ARHGAP12 | 0.02 | 0.94502 | 0.17 | 0.4478 | miRNAWalker2 validate; miRNATAP | -0.21 | 0 | NA | |
55 | hsa-miR-20a-5p | ARHGAP24 | 0.02 | 0.94502 | -0.35 | 0.04577 | MirTarget | -0.22 | 0 | NA | |
56 | hsa-miR-20a-5p | ARHGAP26 | 0.02 | 0.94502 | 0.09 | 0.67346 | MirTarget; mirMAP; miRNATAP | -0.19 | 0 | NA | |
57 | hsa-miR-30d-5p | ARHGAP26 | 0.11 | 0.82546 | 0.09 | 0.67346 | MirTarget | -0.19 | 8.0E-5 | NA | |
58 | hsa-miR-30d-5p | ARHGAP28 | 0.11 | 0.82546 | 0.15 | 0.37632 | mirMAP | -0.36 | 0 | NA | |
59 | hsa-miR-20a-5p | ARHGEF3 | 0.02 | 0.94502 | -0.3 | 0.18309 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
60 | hsa-miR-20a-5p | ARHGEF38 | 0.02 | 0.94502 | -0.62 | 0.00081 | mirMAP | -0.75 | 0 | NA | |
61 | hsa-miR-20a-5p | ARID4A | 0.02 | 0.94502 | -0.08 | 0.70325 | MirTarget; miRNATAP | -0.23 | 0 | NA | |
62 | hsa-miR-20a-5p | ARL13B | 0.02 | 0.94502 | 0.1 | 0.52833 | MirTarget | -0.13 | 0 | NA | |
63 | hsa-miR-30d-5p | ARL15 | 0.11 | 0.82546 | -0.32 | 0.09697 | MirTarget | -0.29 | 0 | NA | |
64 | hsa-miR-20a-5p | ARNT2 | 0.02 | 0.94502 | -0.37 | 0.11922 | mirMAP | -0.23 | 0 | NA | |
65 | hsa-miR-30d-5p | ARRDC4 | 0.11 | 0.82546 | -0.16 | 0.46687 | mirMAP | -0.12 | 0.00578 | NA | |
66 | hsa-miR-20a-5p | ARSB | 0.02 | 0.94502 | 0.43 | 0.01303 | mirMAP | -0.12 | 0 | NA | |
67 | hsa-miR-20a-5p | ARSD | 0.02 | 0.94502 | -0.12 | 0.66281 | mirMAP | -0.23 | 0 | NA | |
68 | hsa-miR-30d-5p | ASCC3 | 0.11 | 0.82546 | 0.46 | 0.05204 | MirTarget | -0.17 | 0 | NA | |
69 | hsa-miR-20a-5p | ASH1L | 0.02 | 0.94502 | 0.1 | 0.71962 | miRNATAP | -0.18 | 0 | NA | |
70 | hsa-miR-20a-5p | ASPA | 0.02 | 0.94502 | -1.02 | 0 | mirMAP | -0.49 | 0 | NA | |
71 | hsa-miR-20a-5p | ATE1 | 0.02 | 0.94502 | 0.38 | 0.03232 | MirTarget | -0.3 | 0 | NA | |
72 | hsa-miR-20a-5p | ATF6 | 0.02 | 0.94502 | 0.21 | 0.41477 | mirMAP | -0.11 | 0 | NA | |
73 | hsa-miR-20a-5p | ATG16L1 | 0.02 | 0.94502 | -0.27 | 0.19992 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
74 | hsa-miR-20a-5p | ATL3 | 0.02 | 0.94502 | 0.67 | 0.00106 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.15 | 0 | NA | |
75 | hsa-miR-20a-5p | ATP1A2 | 0.02 | 0.94502 | -1.88 | 0 | MirTarget; miRNATAP | -0.73 | 0 | NA | |
76 | hsa-miR-30d-5p | ATP6V1B2 | 0.11 | 0.82546 | 0.16 | 0.54639 | MirTarget | -0.15 | 0 | NA | |
77 | hsa-miR-30d-5p | ATP7B | 0.11 | 0.82546 | -0.76 | 9.0E-5 | mirMAP | -0.15 | 0.01564 | NA | |
78 | hsa-miR-30d-5p | ATP8B1 | 0.11 | 0.82546 | -0.02 | 0.9455 | miRNATAP | -0.12 | 0.01198 | NA | |
79 | hsa-miR-20a-5p | ATP8B2 | 0.02 | 0.94502 | -0.44 | 0.0611 | miRNAWalker2 validate | -0.24 | 0 | NA | |
80 | hsa-miR-30d-5p | ATP8B2 | 0.11 | 0.82546 | -0.44 | 0.0611 | miRNATAP | -0.21 | 0 | NA | |
81 | hsa-miR-20a-5p | ATRX | 0.02 | 0.94502 | 0.21 | 0.45614 | mirMAP | -0.23 | 0 | NA | |
82 | hsa-miR-20a-5p | ATXN1 | 0.02 | 0.94502 | -0.15 | 0.51707 | miRNATAP | -0.26 | 0 | NA | |
83 | hsa-miR-30d-5p | ATXN1 | 0.11 | 0.82546 | -0.15 | 0.51707 | mirMAP; miRNATAP | -0.17 | 0 | NA | |
84 | hsa-miR-20a-5p | ATXN1L | 0.02 | 0.94502 | 0.37 | 0.14648 | miRNATAP | -0.12 | 0 | NA | |
85 | hsa-miR-20a-5p | B3GALT2 | 0.02 | 0.94502 | -0.46 | 0.00056 | MirTarget | -0.19 | 0 | NA | |
86 | hsa-miR-30d-5p | B4GALT1 | 0.11 | 0.82546 | 0.23 | 0.47712 | mirMAP | -0.13 | 0.00019 | NA | |
87 | hsa-miR-30d-5p | BACH1 | 0.11 | 0.82546 | 0.26 | 0.2497 | miRNATAP | -0.1 | 0.00376 | NA | |
88 | hsa-miR-30d-5p | BACH2 | 0.11 | 0.82546 | -0.33 | 0.04327 | miRNATAP | -0.14 | 0.026 | NA | |
89 | hsa-miR-20a-5p | BBX | 0.02 | 0.94502 | 0.2 | 0.4569 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
90 | hsa-miR-20a-5p | BCAS1 | 0.02 | 0.94502 | -0.92 | 0.0007 | mirMAP | -1.02 | 0 | NA | |
91 | hsa-miR-20a-5p | BCL2 | 0.02 | 0.94502 | -0.49 | 0.08674 | miRNAWalker2 validate; miRTarBase | -0.4 | 0 | 27044389 | We found that upregulated expression of miR-17 and miR-20a correlates with lack of pro-apoptotic Bim expression |
92 | hsa-miR-20a-5p | BCL2L11 | 0.02 | 0.94502 | 0.05 | 0.80975 | miRNATAP | -0.11 | 0 | 27044389 | We found that upregulated expression of miR-17 and miR-20a correlates with lack of pro-apoptotic Bim expression |
93 | hsa-miR-20a-5p | BCL6 | 0.02 | 0.94502 | -0.15 | 0.56483 | miRNATAP | -0.12 | 0 | NA | |
94 | hsa-miR-20a-5p | BHLHE41 | 0.02 | 0.94502 | -0.42 | 0.10013 | miRNATAP | -0.12 | 0.00097 | NA | |
95 | hsa-miR-20a-5p | BMPR2 | 0.02 | 0.94502 | 0.07 | 0.81221 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.25 | 0 | NA | |
96 | hsa-miR-20a-5p | BNC2 | 0.02 | 0.94502 | -0.23 | 0.21926 | miRNATAP | -0.5 | 0 | NA | |
97 | hsa-miR-30d-5p | BNC2 | 0.11 | 0.82546 | -0.23 | 0.21926 | mirMAP; miRNATAP | -0.5 | 0 | NA | |
98 | hsa-miR-20a-5p | BNIP3L | 0.02 | 0.94502 | -0.08 | 0.78998 | MirTarget | -0.24 | 0 | NA | |
99 | hsa-miR-30d-5p | BNIP3L | 0.11 | 0.82546 | -0.08 | 0.78998 | MirTarget; miRNATAP | -0.18 | 0 | NA | |
100 | hsa-miR-20a-5p | BTBD7 | 0.02 | 0.94502 | -0.01 | 0.97477 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
101 | hsa-miR-20a-5p | BTG2 | 0.02 | 0.94502 | -1.38 | 3.0E-5 | miRNATAP | -0.35 | 0 | NA | |
102 | hsa-miR-20a-5p | C14orf28 | 0.02 | 0.94502 | -0.26 | 0.02466 | miRNATAP | -0.17 | 0 | NA | |
103 | hsa-miR-20a-5p | C16orf52 | 0.02 | 0.94502 | -0.09 | 0.62126 | miRNATAP | -0.14 | 0 | NA | |
104 | hsa-miR-20a-5p | C2CD2 | 0.02 | 0.94502 | -0.22 | 0.35105 | MirTarget; miRNATAP | -0.11 | 0.00018 | NA | |
105 | hsa-miR-20a-5p | C3orf70 | 0.02 | 0.94502 | 0.13 | 0.36578 | miRNATAP | -0.18 | 0 | NA | |
106 | hsa-miR-20a-5p | C5orf24 | 0.02 | 0.94502 | 0.11 | 0.66503 | mirMAP | -0.17 | 0 | NA | |
107 | hsa-miR-20a-5p | C5orf51 | 0.02 | 0.94502 | 0.33 | 0.14181 | mirMAP | -0.1 | 0 | NA | |
108 | hsa-miR-20a-5p | C6orf120 | 0.02 | 0.94502 | -0.06 | 0.79521 | mirMAP | -0.16 | 0 | NA | |
109 | hsa-miR-20a-5p | C9orf47 | 0.02 | 0.94502 | -0.51 | 2.0E-5 | mirMAP | -0.3 | 0 | NA | |
110 | hsa-miR-20a-5p | C9orf66 | 0.02 | 0.94502 | -0.56 | 0 | mirMAP | -0.18 | 0 | NA | |
111 | hsa-miR-20a-5p | CA5B | 0.02 | 0.94502 | -0.12 | 0.49167 | mirMAP | -0.19 | 0 | NA | |
112 | hsa-miR-30d-5p | CACNA1C | 0.11 | 0.82546 | -0.53 | 0.0051 | mirMAP | -0.14 | 0.00713 | NA | |
113 | hsa-miR-20a-5p | CADM2 | 0.02 | 0.94502 | -0.49 | 0.02007 | MirTarget; miRNATAP | -0.45 | 0 | NA | |
114 | hsa-miR-30d-5p | CADPS | 0.11 | 0.82546 | -0.33 | 0.07102 | miRNATAP | -0.34 | 3.0E-5 | NA | |
115 | hsa-miR-20a-5p | CALD1 | 0.02 | 0.94502 | 0.21 | 0.54601 | miRNATAP | -0.13 | 0 | NA | |
116 | hsa-miR-20a-5p | CALN1 | 0.02 | 0.94502 | -1.5 | 0 | mirMAP | -0.43 | 0 | NA | |
117 | hsa-miR-30d-5p | CALN1 | 0.11 | 0.82546 | -1.5 | 0 | mirMAP | -0.24 | 0.02307 | NA | |
118 | hsa-miR-30d-5p | CALU | 0.11 | 0.82546 | 0.62 | 0.04505 | MirTarget | -0.18 | 0 | NA | |
119 | hsa-miR-30d-5p | CAMK2A | 0.11 | 0.82546 | -0.02 | 0.87803 | mirMAP | -0.5 | 0 | NA | |
120 | hsa-miR-20a-5p | CAMK2N1 | 0.02 | 0.94502 | -0.52 | 0.03614 | miRNATAP | -0.33 | 0 | NA | |
121 | hsa-miR-30d-5p | CAMK4 | 0.11 | 0.82546 | -0.13 | 0.31898 | MirTarget; mirMAP | -0.28 | 2.0E-5 | NA | |
122 | hsa-miR-30d-5p | CAPN5 | 0.11 | 0.82546 | -0.33 | 0.0409 | MirTarget; miRNATAP | -0.13 | 0.00503 | NA | |
123 | hsa-miR-30d-5p | CAPZA1 | 0.11 | 0.82546 | 0.38 | 0.18619 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
124 | hsa-miR-20a-5p | CASC4 | 0.02 | 0.94502 | 0.09 | 0.74348 | MirTarget | -0.27 | 0 | NA | |
125 | hsa-miR-20a-5p | CASP8 | 0.02 | 0.94502 | 0.1 | 0.62135 | MirTarget | -0.12 | 0 | NA | |
126 | hsa-miR-20a-5p | CAV1 | 0.02 | 0.94502 | -0.64 | 0.05014 | miRNATAP | -0.31 | 0 | NA | |
127 | hsa-miR-20a-5p | CAV2 | 0.02 | 0.94502 | -0.3 | 0.25751 | mirMAP | -0.12 | 0.00327 | NA | |
128 | hsa-miR-30d-5p | CBLB | 0.11 | 0.82546 | 0.18 | 0.34561 | MirTarget; mirMAP | -0.11 | 1.0E-5 | NA | |
129 | hsa-miR-20a-5p | CBLN4 | 0.02 | 0.94502 | -1.31 | 0 | miRNATAP | -0.72 | 0 | NA | |
130 | hsa-miR-20a-5p | CBX7 | 0.02 | 0.94502 | -0.92 | 0.0002 | mirMAP | -0.18 | 0 | NA | |
131 | hsa-miR-20a-5p | CCBE1 | 0.02 | 0.94502 | -0.18 | 0.24299 | mirMAP | -0.26 | 0 | NA | |
132 | hsa-miR-20a-5p | CCDC103 | 0.02 | 0.94502 | -0.34 | 0.01894 | mirMAP | -0.23 | 0 | NA | |
133 | hsa-miR-20a-5p | CCDC125 | 0.02 | 0.94502 | -0.33 | 0.08478 | mirMAP | -0.3 | 0 | NA | |
134 | hsa-miR-20a-5p | CCND1 | 0.02 | 0.94502 | -0.14 | 0.69562 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.22 | 0 | NA | |
135 | hsa-miR-20a-5p | CCND2 | 0.02 | 0.94502 | -0.14 | 0.53369 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.24 | 0 | NA | |
136 | hsa-miR-20a-5p | CCNG2 | 0.02 | 0.94502 | -0.38 | 0.1693 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
137 | hsa-miR-30d-5p | CCNJL | 0.11 | 0.82546 | 0.09 | 0.52275 | miRNATAP | -0.3 | 0 | NA | |
138 | hsa-miR-20a-5p | CCNT2 | 0.02 | 0.94502 | 0.11 | 0.62342 | miRNATAP | -0.13 | 0 | NA | |
139 | hsa-miR-20a-5p | CD274 | 0.02 | 0.94502 | 0.3 | 0.01527 | MirTarget; miRNATAP | -0.13 | 0.00251 | NA | |
140 | hsa-miR-20a-5p | CD69 | 0.02 | 0.94502 | -0.81 | 0 | miRNATAP | -0.11 | 0.01727 | NA | |
141 | hsa-miR-30d-5p | CDH13 | 0.11 | 0.82546 | 0.15 | 0.45179 | miRNATAP | -0.21 | 0 | NA | |
142 | hsa-miR-20a-5p | CDHR3 | 0.02 | 0.94502 | -0.22 | 0.24837 | mirMAP | -0.28 | 0 | NA | |
143 | hsa-miR-20a-5p | CDKN1A | 0.02 | 0.94502 | -0.08 | 0.76832 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 2.0E-5 | 26012475 | Using the poorly tumorigenic and TGF-β-sensitive FET cell line that expresses low miR-20a levels we first confirmed that miR-20a downmodulated CDKN1A expression both at mRNA and protein level through direct binding to its 3'-UTR; Moreover besides modulating CDKN1A miR-20a blocked TGF-β-induced transactivation of its promoter without affecting the post-receptor activation of Smad3/4 effectors directly; Finally miR-20a abrogated the TGF-β-mediated c-Myc repression a direct inhibitor of the CDKN1A promoter activation most likely by reducing the expression of specific MYC-regulating genes from the Smad/E2F-based core repressor complex |
144 | hsa-miR-20a-5p | CELF2 | 0.02 | 0.94502 | -0.3 | 0.21413 | miRNATAP | -0.14 | 0.00019 | NA | |
145 | hsa-miR-30d-5p | CELF2 | 0.11 | 0.82546 | -0.3 | 0.21413 | mirMAP; miRNATAP | -0.13 | 0.02083 | NA | |
146 | hsa-miR-20a-5p | CEP120 | 0.02 | 0.94502 | -0.13 | 0.53966 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.22 | 0 | NA | |
147 | hsa-miR-20a-5p | CEP97 | 0.02 | 0.94502 | 0.49 | 0.00109 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
148 | hsa-miR-20a-5p | CHD9 | 0.02 | 0.94502 | 0.27 | 0.29488 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
149 | hsa-miR-30d-5p | CHL1 | 0.11 | 0.82546 | -1.1 | 1.0E-5 | MirTarget; miRNATAP | -0.44 | 5.0E-5 | NA | |
150 | hsa-miR-30d-5p | CHST1 | 0.11 | 0.82546 | -0.04 | 0.83412 | MirTarget | -0.17 | 0.02702 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TISSUE DEVELOPMENT | 140 | 1518 | 1.321e-17 | 6.144e-14 |
2 | CELL DEVELOPMENT | 131 | 1426 | 2.414e-16 | 5.617e-13 |
3 | EPITHELIUM DEVELOPMENT | 93 | 945 | 1.69e-13 | 2.562e-10 |
4 | REGULATION OF CELL DIFFERENTIATION | 127 | 1492 | 2.202e-13 | 2.562e-10 |
5 | POSITIVE REGULATION OF GENE EXPRESSION | 141 | 1733 | 2.782e-13 | 2.589e-10 |
6 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 143 | 1784 | 5.764e-13 | 4.47e-10 |
7 | INTRACELLULAR SIGNAL TRANSDUCTION | 130 | 1572 | 8.877e-13 | 5.901e-10 |
8 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 80 | 788 | 1.958e-12 | 1.012e-09 |
9 | CIRCULATORY SYSTEM DEVELOPMENT | 80 | 788 | 1.958e-12 | 1.012e-09 |
10 | TUBE DEVELOPMENT | 63 | 552 | 3.561e-12 | 1.657e-09 |
11 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 141 | 1805 | 5.912e-12 | 2.293e-09 |
12 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 93 | 1004 | 5.485e-12 | 2.293e-09 |
13 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 133 | 1672 | 7.515e-12 | 2.69e-09 |
14 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 101 | 1142 | 9.63e-12 | 3.201e-09 |
15 | RESPONSE TO ENDOGENOUS STIMULUS | 118 | 1450 | 3.327e-11 | 1.032e-08 |
16 | HEART DEVELOPMENT | 54 | 466 | 7.364e-11 | 2.141e-08 |
17 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 86 | 957 | 1.74e-10 | 4.497e-08 |
18 | NEUROGENESIS | 113 | 1402 | 1.653e-10 | 4.497e-08 |
19 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 56 | 513 | 3.236e-10 | 7.925e-08 |
20 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 73 | 771 | 4.7e-10 | 1.093e-07 |
21 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 76 | 823 | 6.355e-10 | 1.408e-07 |
22 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 133 | 1791 | 7.819e-10 | 1.654e-07 |
23 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 28 | 167 | 9.464e-10 | 1.915e-07 |
24 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 109 | 1395 | 2.122e-09 | 4.115e-07 |
25 | EMBRYONIC MORPHOGENESIS | 55 | 539 | 5.39e-09 | 1.003e-06 |
26 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 122 | 1656 | 7.08e-09 | 1.267e-06 |
27 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 114 | 1518 | 8.275e-09 | 1.426e-06 |
28 | ORGAN MORPHOGENESIS | 74 | 841 | 8.739e-09 | 1.452e-06 |
29 | TISSUE MORPHOGENESIS | 54 | 533 | 9.539e-09 | 1.531e-06 |
30 | TUBE MORPHOGENESIS | 39 | 323 | 1.059e-08 | 1.643e-06 |
31 | EPITHELIAL CELL DEVELOPMENT | 28 | 186 | 1.132e-08 | 1.698e-06 |
32 | REGULATION OF CELL DEVELOPMENT | 73 | 836 | 1.522e-08 | 2.213e-06 |
33 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 75 | 872 | 1.811e-08 | 2.553e-06 |
34 | POSITIVE REGULATION OF CELL DEVELOPMENT | 49 | 472 | 2.162e-08 | 2.958e-06 |
35 | RESPONSE TO HORMONE | 76 | 893 | 2.261e-08 | 2.961e-06 |
36 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 118 | 1618 | 2.291e-08 | 2.961e-06 |
37 | EMBRYO DEVELOPMENT | 76 | 894 | 2.37e-08 | 2.981e-06 |
38 | PEPTIDYL SERINE MODIFICATION | 24 | 148 | 2.902e-08 | 3.553e-06 |
39 | ACTIN FILAMENT BASED PROCESS | 47 | 450 | 3.492e-08 | 4.167e-06 |
40 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 83 | 1021 | 3.831e-08 | 4.456e-06 |
41 | UROGENITAL SYSTEM DEVELOPMENT | 36 | 299 | 4.188e-08 | 4.753e-06 |
42 | REGULATION OF PROTEIN MODIFICATION PROCESS | 122 | 1710 | 4.427e-08 | 4.904e-06 |
43 | VASCULATURE DEVELOPMENT | 48 | 469 | 4.694e-08 | 5.079e-06 |
44 | NEURON DIFFERENTIATION | 73 | 874 | 9.219e-08 | 9.749e-06 |
45 | BLOOD VESSEL MORPHOGENESIS | 40 | 364 | 9.471e-08 | 9.793e-06 |
46 | PROTEIN PHOSPHORYLATION | 77 | 944 | 1.07e-07 | 1.082e-05 |
47 | REGULATION OF GTPASE ACTIVITY | 60 | 673 | 1.502e-07 | 1.487e-05 |
48 | MORPHOGENESIS OF AN EPITHELIUM | 42 | 400 | 1.618e-07 | 1.569e-05 |
49 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 64 | 740 | 1.725e-07 | 1.638e-05 |
50 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 134 | 1977 | 1.786e-07 | 1.662e-05 |
51 | HEAD DEVELOPMENT | 62 | 709 | 1.837e-07 | 1.676e-05 |
52 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 33 | 278 | 2.133e-07 | 1.908e-05 |
53 | REGULATION OF HYDROLASE ACTIVITY | 98 | 1327 | 2.296e-07 | 2.016e-05 |
54 | EPITHELIAL CELL DIFFERENTIATION | 48 | 495 | 2.407e-07 | 2.074e-05 |
55 | CELLULAR COMPONENT MORPHOGENESIS | 73 | 900 | 2.895e-07 | 2.449e-05 |
56 | ENDOTHELIUM DEVELOPMENT | 17 | 90 | 3.224e-07 | 2.679e-05 |
57 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 60 | 689 | 3.356e-07 | 2.74e-05 |
58 | SINGLE ORGANISM BEHAVIOR | 40 | 384 | 3.923e-07 | 3.148e-05 |
59 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 106 | 1492 | 4.676e-07 | 3.688e-05 |
60 | REGULATION OF NEURON DIFFERENTIATION | 51 | 554 | 5.027e-07 | 3.898e-05 |
61 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 107 | 1517 | 5.805e-07 | 4.428e-05 |
62 | POSITIVE REGULATION OF LOCOMOTION | 42 | 420 | 6.061e-07 | 4.549e-05 |
63 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 34 | 306 | 6.687e-07 | 4.939e-05 |
64 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 72 | 905 | 7.234e-07 | 5.232e-05 |
65 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 78 | 1008 | 7.309e-07 | 5.232e-05 |
66 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 124 | 1848 | 9.405e-07 | 6.63e-05 |
67 | RHYTHMIC PROCESS | 33 | 298 | 1.05e-06 | 7.29e-05 |
68 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 20 | 131 | 1.099e-06 | 7.52e-05 |
69 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 50 | 554 | 1.164e-06 | 7.85e-05 |
70 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 62 | 750 | 1.255e-06 | 8.343e-05 |
71 | NEGATIVE REGULATION OF GENE EXPRESSION | 104 | 1493 | 1.512e-06 | 9.907e-05 |
72 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 60 | 724 | 1.725e-06 | 0.0001115 |
73 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 24 | 184 | 1.806e-06 | 0.0001151 |
74 | REGULATION OF KINASE ACTIVITY | 63 | 776 | 1.882e-06 | 0.0001174 |
75 | BEHAVIOR | 47 | 516 | 1.893e-06 | 0.0001174 |
76 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 78 | 1036 | 2.089e-06 | 0.0001262 |
77 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 78 | 1036 | 2.089e-06 | 0.0001262 |
78 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 36 | 352 | 2.281e-06 | 0.0001361 |
79 | REGULATION OF CELL DEATH | 102 | 1472 | 2.434e-06 | 0.0001434 |
80 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 97 | 1381 | 2.475e-06 | 0.0001439 |
81 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 91 | 1275 | 2.712e-06 | 0.0001558 |
82 | VENTRICULAR SEPTUM DEVELOPMENT | 12 | 54 | 2.933e-06 | 0.0001665 |
83 | NEURON DEVELOPMENT | 57 | 687 | 3.033e-06 | 0.0001686 |
84 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 83 | 1135 | 3.044e-06 | 0.0001686 |
85 | BIOLOGICAL ADHESION | 77 | 1032 | 3.403e-06 | 0.0001863 |
86 | RESPONSE TO NITROGEN COMPOUND | 67 | 859 | 3.501e-06 | 0.0001887 |
87 | PEPTIDYL THREONINE MODIFICATION | 11 | 46 | 3.528e-06 | 0.0001887 |
88 | CARDIAC SEPTUM DEVELOPMENT | 15 | 85 | 3.852e-06 | 0.0002014 |
89 | HEART PROCESS | 15 | 85 | 3.852e-06 | 0.0002014 |
90 | RESPONSE TO MECHANICAL STIMULUS | 25 | 210 | 5.882e-06 | 0.0003041 |
91 | REGULATION OF TRANSPORT | 118 | 1804 | 6.095e-06 | 0.0003082 |
92 | PHOSPHORYLATION | 87 | 1228 | 6.092e-06 | 0.0003082 |
93 | PROTEIN LOCALIZATION | 118 | 1805 | 6.255e-06 | 0.0003129 |
94 | REGULATION OF JNK CASCADE | 21 | 159 | 6.451e-06 | 0.0003193 |
95 | PEPTIDYL AMINO ACID MODIFICATION | 65 | 841 | 6.611e-06 | 0.0003238 |
96 | RESPONSE TO STEROID HORMONE | 44 | 497 | 8.307e-06 | 0.0004026 |
97 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 40 | 437 | 9.763e-06 | 0.0004645 |
98 | EMBRYONIC ORGAN DEVELOPMENT | 38 | 406 | 9.783e-06 | 0.0004645 |
99 | MUSCLE TISSUE DEVELOPMENT | 29 | 275 | 1.207e-05 | 0.0005618 |
100 | ACTIN FILAMENT BASED MOVEMENT | 15 | 93 | 1.207e-05 | 0.0005618 |
101 | ENDOTHELIAL CELL DIFFERENTIATION | 13 | 72 | 1.304e-05 | 0.0006008 |
102 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 14 | 1.55e-05 | 0.0007072 |
103 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 68 | 917 | 1.58e-05 | 0.0007137 |
104 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 50 | 609 | 1.627e-05 | 0.0007279 |
105 | REGULATION OF MAPK CASCADE | 53 | 660 | 1.685e-05 | 0.0007328 |
106 | APPENDAGE DEVELOPMENT | 21 | 169 | 1.673e-05 | 0.0007328 |
107 | LIMB DEVELOPMENT | 21 | 169 | 1.673e-05 | 0.0007328 |
108 | MUSCLE STRUCTURE DEVELOPMENT | 39 | 432 | 1.725e-05 | 0.0007432 |
109 | NEURON PROJECTION DEVELOPMENT | 46 | 545 | 1.776e-05 | 0.0007583 |
110 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 61 | 799 | 1.847e-05 | 0.0007813 |
111 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 41 | 470 | 2.367e-05 | 0.0009924 |
112 | REGULATION OF CELL SUBSTRATE ADHESION | 21 | 173 | 2.391e-05 | 0.0009934 |
113 | REGULATION OF CELL MORPHOGENESIS | 46 | 552 | 2.444e-05 | 0.001006 |
114 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 49 | 602 | 2.471e-05 | 0.001009 |
115 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 37 | 408 | 2.555e-05 | 0.001034 |
116 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 12 | 66 | 2.596e-05 | 0.001041 |
117 | DIGESTIVE SYSTEM DEVELOPMENT | 19 | 148 | 2.633e-05 | 0.001047 |
118 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 43 | 505 | 2.694e-05 | 0.001062 |
119 | LOCOMOTION | 78 | 1114 | 2.833e-05 | 0.001108 |
120 | HOMEOSTATIC PROCESS | 90 | 1337 | 3.011e-05 | 0.001162 |
121 | RESPONSE TO GROWTH FACTOR | 41 | 475 | 3.022e-05 | 0.001162 |
122 | REGULATION OF DEVELOPMENTAL GROWTH | 29 | 289 | 3.071e-05 | 0.001171 |
123 | REGULATION OF CELL PROJECTION ORGANIZATION | 46 | 558 | 3.193e-05 | 0.001194 |
124 | MESENCHYME DEVELOPMENT | 22 | 190 | 3.233e-05 | 0.001194 |
125 | CELL PROJECTION ORGANIZATION | 66 | 902 | 3.19e-05 | 0.001194 |
126 | CELLULAR RESPONSE TO STRESS | 102 | 1565 | 3.219e-05 | 0.001194 |
127 | CIRCULATORY SYSTEM PROCESS | 34 | 366 | 3.308e-05 | 0.001212 |
128 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 32 | 337 | 3.655e-05 | 0.001321 |
129 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 9 | 39 | 3.719e-05 | 0.001321 |
130 | REGULATION OF AXON GUIDANCE | 9 | 39 | 3.719e-05 | 0.001321 |
131 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 34 | 368 | 3.695e-05 | 0.001321 |
132 | REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 16 | 3.833e-05 | 0.001351 |
133 | REGULATION OF TRANSFERASE ACTIVITY | 68 | 946 | 4.212e-05 | 0.00143 |
134 | REGULATION OF CIRCADIAN RHYTHM | 15 | 103 | 4.198e-05 | 0.00143 |
135 | EMBRYONIC ORGAN MORPHOGENESIS | 28 | 279 | 4.174e-05 | 0.00143 |
136 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 42 | 498 | 4.156e-05 | 0.00143 |
137 | DEVELOPMENTAL MATURATION | 22 | 193 | 4.115e-05 | 0.00143 |
138 | NEURON PROJECTION MORPHOGENESIS | 36 | 402 | 4.262e-05 | 0.001437 |
139 | RESPONSE TO OXYGEN LEVELS | 30 | 311 | 4.739e-05 | 0.001586 |
140 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 30 | 312 | 5.029e-05 | 0.001665 |
141 | CELLULAR RESPONSE TO HORMONE STIMULUS | 45 | 552 | 5.07e-05 | 0.001665 |
142 | RESPONSE TO ABIOTIC STIMULUS | 72 | 1024 | 5.08e-05 | 0.001665 |
143 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 11 | 60 | 5.173e-05 | 0.001683 |
144 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 22 | 197 | 5.623e-05 | 0.001814 |
145 | POSITIVE REGULATION OF CELL DEATH | 48 | 605 | 5.653e-05 | 0.001814 |
146 | REGULATION OF CELLULAR RESPONSE TO STRESS | 53 | 691 | 5.771e-05 | 0.001839 |
147 | ACTION POTENTIAL | 14 | 94 | 5.833e-05 | 0.001846 |
148 | POSITIVE REGULATION OF CELL COMMUNICATION | 99 | 1532 | 5.898e-05 | 0.001854 |
149 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 93 | 1423 | 6.66e-05 | 0.00208 |
150 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 59 | 801 | 6.976e-05 | 0.002153 |
151 | SENSORY ORGAN DEVELOPMENT | 41 | 493 | 6.986e-05 | 0.002153 |
152 | POSITIVE REGULATION OF OSSIFICATION | 13 | 84 | 7.088e-05 | 0.00217 |
153 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 24 | 229 | 7.333e-05 | 0.00223 |
154 | ACTIVATION OF MAPKK ACTIVITY | 10 | 52 | 7.392e-05 | 0.002233 |
155 | CHEMICAL HOMEOSTASIS | 63 | 874 | 7.45e-05 | 0.002236 |
156 | WNT SIGNALING PATHWAY | 32 | 351 | 7.982e-05 | 0.002381 |
157 | RESPONSE TO DRUG | 37 | 431 | 8.151e-05 | 0.002416 |
158 | GLAND MORPHOGENESIS | 14 | 97 | 8.289e-05 | 0.002441 |
159 | MYELOID CELL DIFFERENTIATION | 21 | 189 | 8.851e-05 | 0.00259 |
160 | POSITIVE REGULATION OF KINASE ACTIVITY | 40 | 482 | 8.932e-05 | 0.002598 |
161 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 24 | 232 | 9e-05 | 0.002601 |
162 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 19 | 162 | 9.194e-05 | 0.002641 |
163 | NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 14 | 98 | 9.287e-05 | 0.002651 |
164 | MULTICELLULAR ORGANISMAL SIGNALING | 16 | 123 | 9.528e-05 | 0.002677 |
165 | STEM CELL DIFFERENTIATION | 21 | 190 | 9.549e-05 | 0.002677 |
166 | PATTERN SPECIFICATION PROCESS | 36 | 418 | 9.488e-05 | 0.002677 |
167 | ANGIOGENESIS | 28 | 293 | 9.845e-05 | 0.002727 |
168 | EMBRYONIC CAMERA TYPE EYE FORMATION | 5 | 12 | 9.81e-05 | 0.002727 |
169 | CIRCADIAN RHYTHM | 17 | 137 | 0.0001057 | 0.002911 |
170 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 118 | 1929 | 0.0001164 | 0.003185 |
171 | COGNITION | 25 | 251 | 0.0001192 | 0.003224 |
172 | OSSIFICATION | 25 | 251 | 0.0001192 | 0.003224 |
173 | VESICLE MEDIATED TRANSPORT | 82 | 1239 | 0.0001215 | 0.003269 |
174 | ENDOCHONDRAL BONE MORPHOGENESIS | 9 | 45 | 0.0001228 | 0.003285 |
175 | NEGATIVE REGULATION OF CELL DEATH | 62 | 872 | 0.0001246 | 0.003312 |
176 | REPRODUCTIVE SYSTEM DEVELOPMENT | 35 | 408 | 0.0001276 | 0.003354 |
177 | GLYCOSYLATION | 26 | 267 | 0.0001271 | 0.003354 |
178 | REGULATION OF SYSTEM PROCESS | 41 | 507 | 0.0001287 | 0.003357 |
179 | REGULATION OF CHEMOTAXIS | 20 | 180 | 0.0001291 | 0.003357 |
180 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 77 | 1152 | 0.0001445 | 0.003735 |
181 | SODIUM ION TRANSMEMBRANE TRANSPORT | 13 | 90 | 0.0001461 | 0.003757 |
182 | RESPONSE TO WOUNDING | 44 | 563 | 0.0001599 | 0.004065 |
183 | REGULATION OF VESICLE MEDIATED TRANSPORT | 38 | 462 | 0.0001594 | 0.004065 |
184 | RESPONSE TO INORGANIC SUBSTANCE | 39 | 479 | 0.0001621 | 0.004098 |
185 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 37 | 0.0001646 | 0.004139 |
186 | HEART MORPHOGENESIS | 22 | 212 | 0.0001663 | 0.004161 |
187 | REGULATION OF CELL JUNCTION ASSEMBLY | 11 | 68 | 0.0001682 | 0.004185 |
188 | IMMUNE SYSTEM DEVELOPMENT | 45 | 582 | 0.0001721 | 0.004238 |
189 | BONE DEVELOPMENT | 18 | 156 | 0.0001716 | 0.004238 |
190 | CELLULAR RESPONSE TO OXYGEN LEVELS | 17 | 143 | 0.0001794 | 0.004394 |
191 | EXTRACELLULAR STRUCTURE ORGANIZATION | 28 | 304 | 0.0001839 | 0.00448 |
192 | CARDIAC CHAMBER DEVELOPMENT | 17 | 144 | 0.0001953 | 0.004733 |
193 | GLYCOPROTEIN METABOLIC PROCESS | 31 | 353 | 0.0002013 | 0.004852 |
194 | RESPONSE TO ISCHEMIA | 7 | 29 | 0.0002036 | 0.004857 |
195 | CARDIAC MUSCLE CELL CONTRACTION | 7 | 29 | 0.0002036 | 0.004857 |
196 | DIGESTIVE TRACT MORPHOGENESIS | 9 | 48 | 0.0002067 | 0.004906 |
197 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 34 | 404 | 0.000227 | 0.005362 |
198 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 17 | 146 | 0.0002308 | 0.005396 |
199 | UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 5 | 14 | 0.0002304 | 0.005396 |
200 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 16 | 133 | 0.0002399 | 0.005581 |
201 | SKELETAL SYSTEM DEVELOPMENT | 37 | 455 | 0.0002421 | 0.005589 |
202 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 8 | 39 | 0.0002427 | 0.005589 |
203 | REGULATION OF METAL ION TRANSPORT | 29 | 325 | 0.0002442 | 0.005597 |
204 | FOREBRAIN DEVELOPMENT | 31 | 357 | 0.0002455 | 0.005599 |
205 | NEGATIVE REGULATION OF CELL COMMUNICATION | 78 | 1192 | 0.0002534 | 0.005751 |
206 | MESENCHYMAL CELL DIFFERENTIATION | 16 | 134 | 0.0002616 | 0.005908 |
207 | NEURON PROJECTION GUIDANCE | 21 | 205 | 0.000277 | 0.006227 |
208 | MEMBRANE DEPOLARIZATION | 10 | 61 | 0.0002951 | 0.006507 |
209 | EMBRYONIC DIGIT MORPHOGENESIS | 10 | 61 | 0.0002951 | 0.006507 |
210 | DEVELOPMENTAL PIGMENTATION | 8 | 40 | 0.0002918 | 0.006507 |
211 | REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 14 | 109 | 0.0002925 | 0.006507 |
212 | GROWTH | 34 | 410 | 0.0002982 | 0.006544 |
213 | REGULATION OF LIPID METABOLIC PROCESS | 26 | 282 | 0.000303 | 0.00662 |
214 | PROTEIN AUTOPHOSPHORYLATION | 20 | 192 | 0.0003079 | 0.006694 |
215 | POSITIVE REGULATION OF CATABOLIC PROCESS | 33 | 395 | 0.0003184 | 0.006832 |
216 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 46 | 616 | 0.0003195 | 0.006832 |
217 | MUSCLE CELL DIFFERENTIATION | 23 | 237 | 0.0003201 | 0.006832 |
218 | REGULATION OF OSSIFICATION | 19 | 178 | 0.0003164 | 0.006832 |
219 | FORMATION OF PRIMARY GERM LAYER | 14 | 110 | 0.0003219 | 0.00684 |
220 | POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 5 | 15 | 0.0003332 | 0.007015 |
221 | REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 5 | 15 | 0.0003332 | 0.007015 |
222 | MEMORY | 13 | 98 | 0.0003464 | 0.007227 |
223 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 13 | 98 | 0.0003464 | 0.007227 |
224 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 26 | 285 | 0.000357 | 0.007415 |
225 | ACTIN MEDIATED CELL CONTRACTION | 11 | 74 | 0.0003612 | 0.007469 |
226 | REGULATION OF EPITHELIAL CELL MIGRATION | 18 | 166 | 0.0003718 | 0.007655 |
227 | EAR DEVELOPMENT | 20 | 195 | 0.0003773 | 0.007733 |
228 | NEGATIVE REGULATION OF CELL CYCLE | 35 | 433 | 0.0003941 | 0.008042 |
229 | PROTEIN N LINKED GLYCOSYLATION | 11 | 75 | 0.0004068 | 0.008194 |
230 | ARTERY DEVELOPMENT | 11 | 75 | 0.0004068 | 0.008194 |
231 | REGULATION OF MAP KINASE ACTIVITY | 28 | 319 | 0.0004045 | 0.008194 |
232 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 60 | 876 | 0.0004236 | 0.008495 |
233 | RESPIRATORY SYSTEM DEVELOPMENT | 20 | 197 | 0.0004308 | 0.008603 |
234 | CELL FATE COMMITMENT | 22 | 227 | 0.0004358 | 0.008666 |
235 | NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 9 | 53 | 0.000449 | 0.00889 |
236 | POSITIVE REGULATION OF MAPK CASCADE | 37 | 470 | 0.0004517 | 0.008905 |
237 | GASTRULATION | 17 | 155 | 0.0004687 | 0.009202 |
238 | REGULATION OF ION TRANSPORT | 44 | 592 | 0.0004722 | 0.009232 |
239 | EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 6 | 24 | 0.0004768 | 0.009282 |
240 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 37 | 472 | 0.0004893 | 0.009486 |
241 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 41 | 541 | 0.0004948 | 0.009514 |
242 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 41 | 541 | 0.0004948 | 0.009514 |
243 | REGULATION OF CELLULAR LOCALIZATION | 81 | 1277 | 0.0005043 | 0.009656 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 96 | 1199 | 6.434e-09 | 1.993e-06 |
2 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 40 | 328 | 5.154e-09 | 1.993e-06 |
3 | ENZYME BINDING | 128 | 1737 | 2.781e-09 | 1.993e-06 |
4 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 60 | 629 | 1.35e-08 | 3.135e-06 |
5 | MACROMOLECULAR COMPLEX BINDING | 104 | 1399 | 6.774e-08 | 1.259e-05 |
6 | KINASE ACTIVITY | 71 | 842 | 9.648e-08 | 1.494e-05 |
7 | CYTOSKELETAL PROTEIN BINDING | 69 | 819 | 1.524e-07 | 2.022e-05 |
8 | CALCIUM ION BINDING | 61 | 697 | 2.25e-07 | 2.613e-05 |
9 | ACTIN BINDING | 40 | 393 | 7.144e-07 | 6.023e-05 |
10 | PROTEIN KINASE ACTIVITY | 56 | 640 | 7.163e-07 | 6.023e-05 |
11 | REGULATORY REGION NUCLEIC ACID BINDING | 67 | 818 | 6.431e-07 | 6.023e-05 |
12 | RIBONUCLEOTIDE BINDING | 125 | 1860 | 7.78e-07 | 6.023e-05 |
13 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 34 | 315 | 1.301e-06 | 9.297e-05 |
14 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 75 | 992 | 2.846e-06 | 0.0001888 |
15 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 32 | 303 | 4.212e-06 | 0.0002446 |
16 | SEQUENCE SPECIFIC DNA BINDING | 77 | 1037 | 4.062e-06 | 0.0002446 |
17 | PROTEIN COMPLEX BINDING | 71 | 935 | 4.551e-06 | 0.0002487 |
18 | DOUBLE STRANDED DNA BINDING | 60 | 764 | 9.292e-06 | 0.0004796 |
19 | VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 7 | 20 | 1.428e-05 | 0.0006935 |
20 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 40 | 445 | 1.493e-05 | 0.0006935 |
21 | MOLECULAR FUNCTION REGULATOR | 91 | 1353 | 2.8e-05 | 0.001239 |
22 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 15 | 105 | 5.275e-05 | 0.002228 |
23 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 24 | 226 | 5.947e-05 | 0.002374 |
24 | PROTEIN DOMAIN SPECIFIC BINDING | 49 | 624 | 6.132e-05 | 0.002374 |
25 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 24 | 228 | 6.842e-05 | 0.002542 |
26 | ADENYL NUCLEOTIDE BINDING | 97 | 1514 | 9.68e-05 | 0.003459 |
27 | HORMONE BINDING | 11 | 65 | 0.0001107 | 0.003808 |
28 | CALMODULIN BINDING | 20 | 179 | 0.0001196 | 0.003968 |
29 | PROTEIN DIMERIZATION ACTIVITY | 77 | 1149 | 0.0001331 | 0.004122 |
30 | TRANSCRIPTION FACTOR BINDING | 42 | 524 | 0.0001299 | 0.004122 |
31 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 19 | 168 | 0.0001494 | 0.004477 |
32 | RECEPTOR BINDING | 94 | 1476 | 0.0001544 | 0.004482 |
33 | PROTEIN HOMODIMERIZATION ACTIVITY | 53 | 722 | 0.0001761 | 0.004959 |
34 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 92 | 0.0001832 | 0.005005 |
35 | KINASE BINDING | 46 | 606 | 0.0002221 | 0.005732 |
36 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 32 | 371 | 0.0002216 | 0.005732 |
37 | GTPASE BINDING | 27 | 295 | 0.0002633 | 0.006611 |
38 | SMAD BINDING | 11 | 72 | 0.0002828 | 0.006913 |
39 | SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 136 | 0.00031 | 0.007385 |
40 | CAMP BINDING | 6 | 23 | 0.0003712 | 0.008622 |
41 | METALLOENDOPEPTIDASE ACTIVITY | 14 | 113 | 0.0004258 | 0.009647 |
42 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 9 | 53 | 0.000449 | 0.009931 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 95 | 1151 | 1.676e-09 | 9.788e-07 |
2 | MEMBRANE REGION | 93 | 1134 | 3.486e-09 | 1.018e-06 |
3 | CELL LEADING EDGE | 40 | 350 | 3.234e-08 | 6.296e-06 |
4 | GOLGI APPARATUS | 106 | 1445 | 9.763e-08 | 1.425e-05 |
5 | CELL SUBSTRATE JUNCTION | 41 | 398 | 3.78e-07 | 4.01e-05 |
6 | PLASMA MEMBRANE REGION | 74 | 929 | 4.807e-07 | 4.01e-05 |
7 | CELL PROJECTION | 122 | 1786 | 4.649e-07 | 4.01e-05 |
8 | ANCHORING JUNCTION | 46 | 489 | 1.007e-06 | 7.35e-05 |
9 | INTRACELLULAR VESICLE | 90 | 1259 | 2.898e-06 | 0.0001881 |
10 | MEMBRANE MICRODOMAIN | 31 | 288 | 4.007e-06 | 0.000234 |
11 | NEURON PART | 89 | 1265 | 6.227e-06 | 0.0003306 |
12 | NEURON PROJECTION | 70 | 942 | 1.103e-05 | 0.0005368 |
13 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 6 | 14 | 1.55e-05 | 0.0006964 |
14 | T TUBULE | 10 | 45 | 1.968e-05 | 0.0008181 |
15 | PLASMA MEMBRANE RAFT | 14 | 86 | 2.101e-05 | 0.0008181 |
16 | PROTEIN KINASE COMPLEX | 14 | 90 | 3.558e-05 | 0.001299 |
17 | ORGANELLE SUBCOMPARTMENT | 30 | 311 | 4.739e-05 | 0.001628 |
18 | GOLGI CISTERNA | 14 | 93 | 5.17e-05 | 0.001677 |
19 | SODIUM CHANNEL COMPLEX | 6 | 17 | 5.704e-05 | 0.001753 |
20 | ACTIN CYTOSKELETON | 38 | 444 | 6.998e-05 | 0.001946 |
21 | LAMELLIPODIUM | 20 | 172 | 6.856e-05 | 0.001946 |
22 | TRANSFERASE COMPLEX | 53 | 703 | 9.006e-05 | 0.002391 |
23 | GOLGI STACK | 16 | 125 | 0.0001156 | 0.002936 |
24 | SYNAPSE | 55 | 754 | 0.0001569 | 0.003819 |
25 | CYTOSKELETON | 119 | 1967 | 0.0001708 | 0.003854 |
26 | RUFFLE | 18 | 156 | 0.0001716 | 0.003854 |
27 | CELL CELL JUNCTION | 33 | 383 | 0.0001814 | 0.003924 |
28 | ACTIN FILAMENT | 11 | 70 | 0.0002192 | 0.004573 |
29 | GOLGI APPARATUS PART | 62 | 893 | 0.0002381 | 0.004738 |
30 | ENDOPLASMIC RETICULUM | 101 | 1631 | 0.0002434 | 0.004738 |
31 | LEADING EDGE MEMBRANE | 16 | 134 | 0.0002616 | 0.004927 |
32 | POSTSYNAPSE | 32 | 378 | 0.0003091 | 0.005642 |
33 | ACTOMYOSIN | 10 | 62 | 0.0003382 | 0.005986 |
34 | EARLY ENDOSOME | 27 | 301 | 0.0003627 | 0.00623 |
35 | CYTOPLASMIC REGION | 26 | 287 | 0.0003975 | 0.006448 |
36 | ACTIN BASED CELL PROJECTION | 19 | 181 | 0.000391 | 0.006448 |
37 | CELL CELL CONTACT ZONE | 10 | 64 | 0.0004403 | 0.00695 |
38 | VACUOLE | 76 | 1180 | 0.0004847 | 0.007448 |
39 | ENDOPLASMIC RETICULUM LUMEN | 20 | 201 | 0.0005579 | 0.008146 |
40 | GOLGI MEMBRANE | 50 | 703 | 0.0005494 | 0.008146 |
41 | APICAL PART OF CELL | 30 | 361 | 0.0006375 | 0.008865 |
42 | CELL PROJECTION PART | 63 | 946 | 0.0006356 | 0.008865 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | FoxO_signaling_pathway_hsa04068 | 22 | 132 | 6.577e-08 | 3.42e-06 | |
2 | Sphingolipid_signaling_pathway_hsa04071 | 18 | 118 | 3.794e-06 | 9.866e-05 | |
3 | Focal_adhesion_hsa04510 | 24 | 199 | 7.188e-06 | 0.0001246 | |
4 | Rap1_signaling_pathway_hsa04015 | 22 | 206 | 0.0001095 | 0.001317 | |
5 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 17 | 139 | 0.0001266 | 0.001317 | |
6 | PI3K_Akt_signaling_pathway_hsa04151 | 31 | 352 | 0.0001914 | 0.001454 | |
7 | Endocytosis_hsa04144 | 24 | 244 | 0.0001957 | 0.001454 | |
8 | HIF_1_signaling_pathway_hsa04066 | 13 | 100 | 0.0004229 | 0.002749 | |
9 | Cellular_senescence_hsa04218 | 17 | 160 | 0.0006757 | 0.003754 | |
10 | p53_signaling_pathway_hsa04115 | 10 | 68 | 0.0007219 | 0.003754 | |
11 | Hedgehog_signaling_pathway_hsa04340 | 8 | 47 | 0.0009101 | 0.004302 | |
12 | Tight_junction_hsa04530 | 17 | 170 | 0.001331 | 0.005767 | |
13 | Autophagy_animal_hsa04140 | 14 | 128 | 0.001476 | 0.005898 | |
14 | Gap_junction_hsa04540 | 11 | 88 | 0.001588 | 0.005898 | |
15 | AMPK_signaling_pathway_hsa04152 | 13 | 121 | 0.002518 | 0.008396 | |
16 | mTOR_signaling_pathway_hsa04150 | 15 | 151 | 0.002657 | 0.008396 | |
17 | TNF_signaling_pathway_hsa04668 | 12 | 108 | 0.002745 | 0.008396 | |
18 | Hippo_signaling_pathway_hsa04390 | 15 | 154 | 0.00321 | 0.009274 | |
19 | ErbB_signaling_pathway_hsa04012 | 10 | 85 | 0.003989 | 0.01092 | |
20 | cGMP_PKG_signaling_pathway_hsa04022 | 15 | 163 | 0.005459 | 0.01405 | |
21 | MAPK_signaling_pathway_hsa04010 | 23 | 295 | 0.005675 | 0.01405 | |
22 | cAMP_signaling_pathway_hsa04024 | 17 | 198 | 0.00646 | 0.01527 | |
23 | Hippo_signaling_pathway_multiple_species_hsa04392 | 5 | 29 | 0.007923 | 0.01791 | |
24 | TGF_beta_signaling_pathway_hsa04350 | 9 | 84 | 0.01121 | 0.02429 | |
25 | Phospholipase_D_signaling_pathway_hsa04072 | 13 | 146 | 0.01207 | 0.0251 | |
26 | Apoptosis_multiple_species_hsa04215 | 5 | 33 | 0.01371 | 0.02743 | |
27 | Apelin_signaling_pathway_hsa04371 | 12 | 137 | 0.01744 | 0.03359 | |
28 | Apoptosis_hsa04210 | 12 | 138 | 0.01837 | 0.03412 | |
29 | Oocyte_meiosis_hsa04114 | 11 | 124 | 0.02046 | 0.03668 | |
30 | Ras_signaling_pathway_hsa04014 | 17 | 232 | 0.02717 | 0.04558 | |
31 | Wnt_signaling_pathway_hsa04310 | 12 | 146 | 0.02717 | 0.04558 | |
32 | Jak_STAT_signaling_pathway_hsa04630 | 12 | 162 | 0.05329 | 0.0866 | |
33 | ECM_receptor_interaction_hsa04512 | 7 | 82 | 0.06807 | 0.1073 | |
34 | Calcium_signaling_pathway_hsa04020 | 12 | 182 | 0.1047 | 0.1601 | |
35 | VEGF_signaling_pathway_hsa04370 | 5 | 59 | 0.116 | 0.1723 | |
36 | Regulation_of_actin_cytoskeleton_hsa04810 | 13 | 208 | 0.1271 | 0.1836 | |
37 | Phosphatidylinositol_signaling_system_hsa04070 | 7 | 99 | 0.1441 | 0.2025 | |
38 | Cytokine_cytokine_receptor_interaction_hsa04060 | 15 | 270 | 0.208 | 0.2775 | |
39 | Adherens_junction_hsa04520 | 5 | 72 | 0.2081 | 0.2775 | |
40 | Peroxisome_hsa04146 | 5 | 83 | 0.2994 | 0.3892 | |
41 | ABC_transporters_hsa02010 | 3 | 45 | 0.3159 | 0.3942 | |
42 | Mitophagy_animal_hsa04137 | 4 | 65 | 0.3184 | 0.3942 | |
43 | Notch_signaling_pathway_hsa04330 | 3 | 48 | 0.3523 | 0.426 | |
44 | Lysosome_hsa04142 | 6 | 123 | 0.4545 | 0.5341 | |
45 | Cell_cycle_hsa04110 | 6 | 124 | 0.4622 | 0.5341 | |
46 | Phagosome_hsa04145 | 7 | 152 | 0.502 | 0.5675 | |
47 | Necroptosis_hsa04217 | 6 | 164 | 0.7301 | 0.8077 | |
48 | Cell_adhesion_molecules_.CAMs._hsa04514 | 5 | 145 | 0.7673 | 0.8142 | |
49 | NF_kappa_B_signaling_pathway_hsa04064 | 3 | 95 | 0.7924 | 0.8241 | |
50 | Neuroactive_ligand_receptor_interaction_hsa04080 | 8 | 278 | 0.9245 | 0.9245 |